Jones T - Search Results

1

2-[11C]thymidine positron emission tomography reproducibility in humans.

Wells P, Gunn RN, Steel C, Ranicar AS, Brady F, Osman S, Jones T, Price P. Wells P, et al. Among authors: jones t. Clin Cancer Res. 2005 Jun 15;11(12):4341-7. doi: 10.1158/1078-0432.CCR-04-1818. Clin Cancer Res. 2005. PMID: 15958616 Free article.

2

Assessment of proliferation in vivo using 2-[(11)C]thymidine positron emission tomography in advanced intra-abdominal malignancies.

Wells P, Gunn RN, Alison M, Steel C, Golding M, Ranicar AS, Brady F, Osman S, Jones T, Price P. Wells P, et al. Among authors: jones t. Cancer Res. 2002 Oct 15;62(20):5698-702. Cancer Res. 2002. PMID: 12384527 Clinical Trial.

3

Metabolic activation of temozolomide measured in vivo using positron emission tomography.

Saleem A, Brown GD, Brady F, Aboagye EO, Osman S, Luthra SK, Ranicar AS, Brock CS, Stevens MF, Newlands E, Jones T, Price P. Saleem A, et al. Among authors: jones t. Cancer Res. 2003 May 15;63(10):2409-15. Cancer Res. 2003. PMID: 12750260

4

Assessment of inter- and intrapatient variability in C15O2 positron emission tomography measurements of blood flow in patients with intra-abdominal cancers.

Wells P, Jones T, Price P. Wells P, et al. Among authors: jones t. Clin Cancer Res. 2003 Dec 15;9(17):6350-6. Clin Cancer Res. 2003. PMID: 14695134

5

Studies on the metabolism of the novel antitumor agent [N-methyl-11C]N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in rats and humans prior to phase I clinical trials.

Osman S, Luthra SK, Brady F, Hume SP, Brown G, Harte RJ, Matthews JC, Denny WA, Baguley BC, Jones T, Price PM. Osman S, et al. Among authors: jones t. Cancer Res. 1997 Jun 1;57(11):2172-80. Cancer Res. 1997. PMID: 9187117 Clinical Trial.

6

Tumor, normal tissue, and plasma pharmacokinetic studies of fluorouracil biomodulation with N-phosphonacetyl-L-aspartate, folinic acid, and interferon alfa.

Harte RJ, Matthews JC, O'Reilly SM, Tilsley DW, Osman S, Brown G, Luthra SJ, Brady F, Jones T, Price PM. Harte RJ, et al. Among authors: jones t. J Clin Oncol. 1999 May;17(5):1580-8. doi: 10.1200/JCO.1999.17.5.1580. J Clin Oncol. 1999. PMID: 10334547

7

On-line measurement of exhaled [11C]CO2 during PET.

Gunn RN, Ranicar A, Yap JT, Wells P, Osman S, Jones T, Cunningham VJ. Gunn RN, et al. Among authors: jones t. J Nucl Med. 2000 Apr;41(4):605-11. J Nucl Med. 2000. PMID: 10768560 Free article.

8

A general method to correct PET data for tissue metabolites using a dual-scan approach.

Gunn RN, Yap JT, Wells P, Osman S, Price P, Jones T, Cunningham VJ. Gunn RN, et al. Among authors: jones t. J Nucl Med. 2000 Apr;41(4):706-11. J Nucl Med. 2000. PMID: 10768573 Free article.

9

Pharmacokinetic evaluation of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in patients by positron emission tomography.

Saleem A, Harte RJ, Matthews JC, Osman S, Brady F, Luthra SK, Brown GD, Bleehen N, Connors T, Jones T, Price PM, Aboagye EO. Saleem A, et al. Among authors: jones t. J Clin Oncol. 2001 Mar 1;19(5):1421-9. doi: 10.1200/JCO.2001.19.5.1421. J Clin Oncol. 2001. PMID: 11230487 Clinical Trial.

10

Positron emission tomography for tumour assessment.

Jones T, Tilsley DW, Wilson CB, Lammertsma AA, Brown G, Brady F, Price PM. Jones T, et al. NMR Biomed. 1992 Sep-Oct;5(5):265-9. doi: 10.1002/nbm.1940050512. NMR Biomed. 1992. PMID: 1449966 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,051 results

Search Page

Filters